QT Pine SR 200 (Quetiapine Fumarate Prolonged Release) 200mg – Sachets
Sustained-Release Antipsychotic Therapy for Mood & Psychotic Disorders
QT Pine SR 200 contains quetiapine fumarate in a prolonged-release formulation designed to provide consistent therapeutic levels throughout the day. It is prescribed for the treatment of schizophrenia, bipolar disorder, and as adjunct therapy in major depressive disorder.
Quetiapine works by modulating key neurotransmitters in the brain, including dopamine and serotonin. This helps reduce symptoms such as hallucinations, delusions, mood instability, agitation, and depressive episodes.
The sustained-release (SR) design allows for gradual medication delivery, which may improve symptom control and simplify dosing schedules. Treatment should be individualised and monitored by a qualified healthcare professional to ensure safety and effectiveness.
Key Benefits
- ✅ Prolonged-release formulation for stable symptom control
- ✅ Used in management of schizophrenia
- ✅ Supports treatment of bipolar disorder (mania and depression)
- ✅ May be used as adjunct therapy in major depressive disorder
- ✅ Once-daily dosing convenience (as prescribed)
Who Is It Intended For?
- Adult patients diagnosed with schizophrenia or bipolar disorder
- Individuals requiring maintenance antipsychotic therapy
- Patients receiving adjunct treatment for major depressive disorder
- Use strictly under specialist psychiatric supervision
QT Pine SR 200 provides sustained therapeutic support for complex mood and psychotic disorders when used as part of a structured treatment plan.
Prescription-only medicine. Do not discontinue abruptly without medical advice.